Baxter International (BAX)
(Delayed Data from NYSE)
$23.09 USD
+0.12 (0.52%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $22.76 -0.33 (-1.43%) 7:58 PM ET
4-Sell of 5 4
A Value F Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Baxter International Inc. has a PEG ratio of 0.73 compared to the Medical - Products industry's PEG ratio of 2.24.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BAX 23.09 +0.12(0.52%)
Will BAX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAX
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for BAX
Peering Into Baxter International Inc's Recent Short Interest
Richard Pzena's Strategic Acquisition in Usana Health Sciences Inc
Richard Pzena's Strategic Reduction in TriMas Corp Holdings
Is BAX showing upside potential? Crossed Above 20 Day Moving Average shows up after climbing 0.97%
BAX forms Directional Movement Crossover Bullish on October 15